Exeliom Biosciences | Microbiome | Oncology | Inflammatory Bowel Disease | Strategic Partnering | Business Coaching

Exeliom develops novel microbiome-solutions focused on enhancing patient’s responsiveness to medical therapy. Drug efficacy can be reduced by dysregulated immunity. Exeliom has novel therapy improvements for inflammatory bowel diseases, solid tumor cancers and selected infectious diseases.

The management team chose me as EIC-sponsored Business Coach.

I reviewed all prior presentations and grant application materials.

In a series of prepared coaching sessions we collaborated on expressing the core value proposition and identified commercialization approaches.

Continued into discussions on commercialization strategy and preparations for corporate dialogue & partnering.

For testimonial: Contact Benjamin Hadida, CEO Exeliom Biosciences